| Jumlah Saham Beredar | 341,272,722 shares |
| Saham Orang Dalam | 114,961,840 shares |
| Kepemilikan oleh Orang Dalam | 33.69 % |
| Orang Dalam Sejati | 43 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
5 ( )
35 out of 11323Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.267 %( )
181 out of 11244Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Nuvation Bio Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Kim D Blickenstaff Director - [D] | 172,189 | 172,189 | |
| Daniel Bradbury Director - [D] | 25,000 | 25,000 | |
| Robert B Bazemore Director - [D] | 5,000 | 5,000 | |
|
Biotech Opportunity GP, LLC
Director, 10% Owner -
[D]
|
1,169,241 | 12,674,775 | |
| Graham K Cooper Director - [D] | 25,000 | 25,000 | |
| Xiangmin Cui Director - [D] | 17,062,202 | 17,062,202 | |
| Michelle Doig Director - [D] | 28,212,373 | 28,212,373 | |
|
EcoR1 Capital Fund Qualified, L.P.
Director, 10% Owner -
[D]
|
1,169,241 | 12,674,775 | |
|
EcoR1 Capital Fund, L.P.
Director, 10% Owner -
[D]
|
1,169,241 | 12,674,775 | |
|
EcoR1 Capital, LLC
Director, 10% Owner -
[D]
|
1,169,241 | 12,674,775 | |
|
EcoR1 Panacea Holdings, LLC
10% Owner -
|
1,355,625 | 1,355,625 | |
|
EcoR1 Venture Opportunity Fund, LP
Director, 10% Owner -
[D]
|
1,169,241 | 12,674,775 | |
| Kathryn E Falberg Director - [D] | 250,000 | 250,000 | |
| Fox Jennifer A. Chief Financial Officer - [O] | 0 | 0 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Hanley David C. | 500,000 | ||
| Faheem Hasnain Director - [D] | 55,000 | 55,000 | |
| Gary Hattersley Chief Scientific Officer - [O] | 0 | 0 | |
|
David Hung
PRESIDENT AND CEO, Director, 10% Owner -
[D]
[O]
|
59,281,054 | 59,281,054 | |
| Dongfang Liu CHIEF MEDICAL OFFICER - [O] | 12,000 | 12,000 | |
| Moses Makunje See Remarks - [O] | 10,612 | 10,612 | |
| Stacy Markel CHIEF PEOPLE OFFICER - [O] | 29,591 | 29,591 | |
| Sarah Marriott | 0 | ||
| Robert Mashal Director - [D] | 200,000 | 200,000 | |
| Oleg Nodelman CEO and Chairman of the Board, Director - [D] [O] | 12,674,775 | 12,674,775 | |
|
Claudio Nessi
10% Owner -
|
0 | 28,212,373 | |
|
Omega Fund IV GP, L.P.
10% Owner -
|
22,957,340 | 22,957,340 | |
|
Omega Fund V GP Manager, Ltd.
10% Owner -
|
20,457,340 | 20,457,340 | |
|
Omega Fund V GP, L.P.
10% Owner -
|
23,457,340 | 20,457,340 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Omega Fund V, L.P.
10% Owner -
|
20,457,340 | 20,457,340 | |
|
Anne-Mari Paster
10% Owner -
|
0 | 28,212,373 | |
| Scott Perlen | 0 | ||
| Scott Platshon | 0 | ||
| Philippe Sauvage Chief Financial Officer - [O] | 9,902 | 9,902 | |
| Shalini Sharp Director - [D] | 35,000 | 35,000 | |
| Colleen Sjogren Chief Commercial Officer - [O] | 81,000 | 81,000 | |
|
Otello Stampacchia
10% Owner -
|
0 | 28,212,373 | |
| Caroline Stout | 0 | ||
| Thomas Templeman SVP, Pharmaceutical Ops - [O] | 0 | 0 | |
| W Anthony Vernon Director - [D] | 0 | 0 | |
| Daniel G Welch Director - [D] | 659,947 | 659,947 | |
| Junyuan Jerry Wang CEO, ANHEART THERAPEUTICS LTD., Director - [D] [O] | 3,866,228 | 3,866,228 | |
| Kerry Wentworth CHIEF REGULATORY OFFICER - [O] | 50,000 | 50,000 | |
| Sergey Yurasov Chief Medical Officer - [O] | 0 | 0 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di NUVB / Nuvation Bio Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di NUVB / Nuvation Bio Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-18 | 2025-06-16 | 4 | Sjogren Colleen | NUVB | Class A Common Stock | D | 1.8070 | 50,000 | 90 | 81,000 | ||||
| 2025-06-18 | 2025-06-17 | 4 | Sauvage Philippe | NUVB | Class A Common Stock | D | 1.7900 | 4,000 | 7 | 9,902 | ||||
| 2025-06-18 | 2025-06-16 | 4 | Sauvage Philippe | NUVB | Class A Common Stock | D | 1.8350 | 3,300 | 6 | 5,902 | ||||
| 2025-06-18 | 2025-06-18 | 4 | Markel Stacy | NUVB | Class A Common Stock | D | 1.7100 | 10,000 | 17 | 29,591 | ||||
| 2025-06-18 | 2025-06-16 | 4 | Hung David | NUVB | Class A Common Stock | D | 1.7870 | 500,000 | 894 | 59,281,054 | ||||
| 2025-06-18 | 2025-06-16 | 4 | Wentworth Kerry | NUVB | Class A Common Stock | D | 1.8000 | 24,000 | 43 | 50,000 | ||||
| 2025-06-18 | 2025-06-16 | 4 | Wentworth Kerry | NUVB | Class A Common Stock | D | 1.7900 | 26,000 | 47 | 26,000 | ||||
| 2025-05-06 | 2025-05-02 | 4 | Liu Dongfang | NUVB | Class A Common Stock | D | 2.5012 | -20,000 | -50 | 12,000 | ||||
| 2025-05-06 | 2025-05-02 | 4 | Liu Dongfang | NUVB | Class A Common Stock | D | 1.9400 | 20,000 | 39 | 32,000 | ||||
| 2025-04-08 | 2025-04-07 | 4 | Hung David | NUVB | Class A Common Stock | D | 1.6250 | 300,000 | 488 | 58,781,054 | ||||
| 2025-04-08 | 2025-04-04 | 4 | Hung David | NUVB | Class A Common Stock | D | 1.6636 | 200,000 | 333 | 58,481,054 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Mashal Robert By Trust | NUVB | Class A Common Stock | I | 1.6699 | 98,900 | 165 | 200,000 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Mashal Robert By Trust | NUVB | Class A Common Stock | I | 1.6655 | 1,100 | 2 | 101,100 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Wang Junyuan Jerry | NUVB | Class A Common Stock | D | 2.8900 | -56,361 | -163 | 3,866,228 | ||||
| 2024-10-10 | 2024-10-08 | 4 | Mashal Robert By Trust | NUVB | Class A Common Stock | I | 2.2000 | 99,981 | 220 | 100,000 | ||||
| 2024-10-10 | 2024-10-08 | 4 | Mashal Robert By Trust | NUVB | Class A Common Stock | I | 2.1950 | 19 | 0 | 19 | ||||
| 2024-09-05 | 2024-09-04 | 4 | Wang Junyuan Jerry By LLC | NUVB | Class A Common Stock | I | 1,695,700 | 2,246,458 | ||||||
| 2024-09-05 | 2024-09-04 | 4 | Wang Junyuan Jerry | NUVB | Class A Common Stock | D | 2,543,600 | 3,922,589 | ||||||
| 2024-09-05 | 2024-09-04 | 4 | Cui Xiangmin By Decheng Anbio Limited | NUVB | Class A Common Stock | I | 12,879,200 | 17,062,202 | ||||||
| 2024-09-05 | 2024-09-04 | 4 | Cui Xiangmin By Decheng Capital Global Healthcare Fund (Master), LP | NUVB | Class A Common Stock | I | 5,157,900 | 7,611,031 | ||||||
| 2024-09-05 | 2024-09-04 | 4 | Cui Xiangmin By Decheng Capital China Life Sciences USD Fund III, L.P. | NUVB | Class A Common Stock | I | 967,100 | 1,281,206 | ||||||
| 2024-06-26 | 2024-06-25 | 4 | Cui Xiangmin By Decheng Capital Global Healthcare Fund (Master), LP | NUVB | Class A Common Stock | I | 2.9700 | 277,895 | 825 | 2,453,131 | ||||
| 2024-06-25 | 2024-06-24 | 4 | Cui Xiangmin By Decheng Capital Global Healthcare Fund (Master), LP | NUVB | Class A Common Stock | I | 2.9800 | 336,874 | 1,004 | 2,175,236 | ||||
| 2024-06-25 | 2024-06-21 | 4 | Cui Xiangmin By Decheng Capital Global Healthcare Fund (Master), LP | NUVB | Class A Common Stock | I | 3.0000 | 75,411 | 226 | 1,838,362 | ||||
| 2024-06-25 | 2024-06-20 | 4 | Cui Xiangmin By Decheng Capital Global Healthcare Fund (Master), LP | NUVB | Class A Common Stock | I | 2.9900 | 87,715 | 262 | 1,762,951 | ||||
| 2024-06-13 | 2024-06-11 | 4 | BLICKENSTAFF KIM D By Trust | NUVB | Class A Common Stock | I | 2.9043 | 172,189 | 500 | 172,189 | ||||
| 2024-05-29 | 2024-05-24 | 4 | WELCH DANIEL G | NUVB | Class A Common Stock | D | 1.6400 | 366,744 | 601 | 659,947 | ||||
| 2024-05-29 | 2024-05-24 | 4 | WELCH DANIEL G | NUVB | Class A Common Stock | D | 1.7400 | 293,203 | 510 | 293,203 | ||||
| 2024-04-11 | 2024-04-09 | 4 | Cui Xiangmin By Decheng Anbio Limited | NUVB | Class A Common Stock | I | 4,183,002 | 4,183,002 | ||||||
| 2024-04-11 | 2024-04-09 | 4 | Cui Xiangmin By Decheng Capital Global Healthcare Fund (Master), LP | NUVB | Class A Common Stock | I | 1,675,236 | 1,675,236 | ||||||
| 2024-04-11 | 2024-04-09 | 4 | Cui Xiangmin By Decheng Capital China Life Sciences USD Fund III, L.P. | NUVB | Class A Common Stock | I | 314,106 | 314,106 | ||||||
| 2024-04-11 | 2024-04-09 | 4 | Wang Junyuan Jerry By LLC | NUVB | Class A Common Stock | I | 550,758 | 550,758 | ||||||
| 2024-04-11 | 2024-04-09 | 4 | Wang Junyuan Jerry | NUVB | Class A Common Stock | D | 1,378,989 | 1,378,989 | ||||||
| 2024-04-02 | 3 | Sjogren Colleen | NUVB | Class A Common Stock | D | 25,000 | ||||||||
| 2023-11-27 | 3 | Makunje Moses | NUVB | Class A Common Stock | D | 10,612 | ||||||||
| 2023-09-22 | 2023-09-21 | 4/A | NODELMAN OLEG See Notes | NUVB | Class A Common Stock | I | 1.3611 | 53,000 | 72 | 12,674,775 | ||||
| 2023-09-22 | 2023-09-20 | 4/A | NODELMAN OLEG See Notes | NUVB | Class A Common Stock | I | 1.3620 | 117,100 | 159 | 12,621,775 | ||||
| 2023-09-22 | 2023-09-19 | 4/A | NODELMAN OLEG See Notes | NUVB | Class A Common Stock | I | 1.2562 | 5,143,000 | 6,461 | 12,504,675 | ||||
| 2023-09-21 | 2023-02-21 | 4 | NODELMAN OLEG See Notes | NUVB | Class A Common Stock | I | 1.3611 | 53,000 | 72 | 12,674,775 | ||||
| 2023-09-21 | 2023-02-20 | 4 | NODELMAN OLEG See Notes | NUVB | Class A Common Stock | I | 1.3620 | 117,100 | 159 | 12,621,775 | ||||
| 2023-09-21 | 2023-02-19 | 4 | NODELMAN OLEG See Notes | NUVB | Class A Common Stock | I | 1.2562 | 5,143,000 | 6,461 | 12,504,675 | ||||
| 2023-03-02 | 2021-03-02 | 4 | Hung David | NUVB | Class A Common Stock | D | -368,408 | 58,281,054 | ||||||
| 2022-12-05 | 2022-12-05 | 4 | FALBERG KATHRYN E By Trust | NUVB | Class A Common Stock | I | 1.9526 | 43,000 | 84 | 250,000 | ||||
| 2022-12-05 | 2022-12-02 | 4 | FALBERG KATHRYN E By Trust | NUVB | Class A Common Stock | I | 1.9827 | 47,000 | 93 | 207,000 | ||||
| 2022-12-05 | 2022-12-01 | 4 | FALBERG KATHRYN E By Trust | NUVB | Class A Common Stock | I | 1.9727 | 84,959 | 168 | 160,000 | ||||
| 2022-12-05 | 2022-11-30 | 4 | FALBERG KATHRYN E By Trust | NUVB | Class A Common Stock | I | 1.8535 | 75,041 | 139 | 75,041 | ||||
| 2022-07-19 | 3 | Liu Dongfang | NUVB | No securities owned. | D | 0 | ||||||||
| 2022-05-25 | 2022-05-23 | 4 | Wentworth Kerry | NUVB | Stock Option (Right to Buy) | D | 3.78 | 247,500 | 247,500 | |||||
| 2022-05-25 | 2022-05-23 | 4 | Wentworth Kerry | NUVB | Stock Option (Right to Buy) | D | 3.78 | 330,000 | 330,000 | |||||
| 2022-05-25 | 3 | Wentworth Kerry | NUVB | No securities owned. | D | 0 | ||||||||
| 2022-05-18 | 2022-05-16 | 4 | BLICKENSTAFF KIM D | NUVB | Stock Option (Right to Buy) | D | 4.05 | 118,784 | 118,784 | |||||
| 2022-05-18 | 2022-05-16 | 4 | Bazemore Robert B | NUVB | Stock Option (Right to Buy) | D | 4.05 | 118,784 | 118,784 | |||||
| 2022-05-18 | 2022-05-16 | 4 | FALBERG KATHRYN E | NUVB | Stock Option (Right to Buy) | D | 4.05 | 118,784 | 118,784 | |||||
| 2022-05-18 | 2022-05-16 | 4 | VERNON W ANTHONY | NUVB | Stock Option (Right to Buy) | D | 4.05 | 118,784 | 118,784 | |||||
| 2022-05-18 | 2022-05-16 | 4 | WELCH DANIEL G | NUVB | Stock Option (Right to Buy) | D | 4.05 | 118,784 | 118,784 | |||||
| 2022-04-07 | 2022-04-05 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 5.6000 | -2,500,000 | -14,000 | 20,457,340 | ||||
| 2022-03-02 | 2022-02-28 | 4 | Hattersley Gary | NUVB | Stock Option (Right to Buy) | D | 5.06 | 500,000 | 500,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Hanley David C. | NUVB | Stock Option (Right to Buy) | D | 5.06 | 500,000 | 500,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Markel Stacy | NUVB | Stock Option (Right to Buy) | D | 5.06 | 500,000 | 500,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Fox Jennifer A. | NUVB | Stock Option (Right to Buy) | D | 5.06 | 600,000 | 600,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Hung David | NUVB | Stock Option (Right to Buy) | D | 5.06 | 2,000,000 | 2,000,000 | |||||
| 2021-12-17 | 2021-12-15 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 10.0700 | -500,000 | -5,035 | 22,957,340 | ||||
| 2021-12-09 | 2021-12-07 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 9.8000 | -1,400,000 | -13,720 | 23,457,340 | ||||
| 2021-11-30 | 2021-11-24 | 4 | NODELMAN OLEG See Notes 2 and 4 | NUVB | Class A Common Stock | I | 7.6859 | 21,758 | 167 | 1,169,241 | ||||
| 2021-11-30 | 2021-11-24 | 4 | NODELMAN OLEG See Notes 2 and 3 | NUVB | Class A Common Stock | I | 7.6859 | 163,268 | 1,255 | 7,361,675 | ||||
| 2021-11-30 | 2021-07-31 | 4 | NODELMAN OLEG See Notes 2 and 4 | NUVB | Class A Common Stock | I | 8.6400 | -56,598 | -489 | 1,147,483 | ||||
| 2021-11-30 | 2021-07-31 | 4 | NODELMAN OLEG See Notes 2 and 3 | NUVB | Class A Common Stock | I | 8.6400 | 56,598 | 489 | 7,198,407 | ||||
| 2021-11-30 | 2021-03-31 | 4 | NODELMAN OLEG See Notes 2 and 4 | NUVB | Class A Common Stock | I | 10.4500 | 151,544 | 1,584 | 1,145,600 | ||||
| 2021-11-30 | 2021-03-31 | 4 | NODELMAN OLEG See Notes 2 and 3 | NUVB | Class A Common Stock | I | 10.4500 | 151,544 | 1,584 | 6,735,790 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 9.7500 | -36 | -0 | 24,857,376 | ||||
| 2021-11-24 | 2021-11-22 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 9.7600 | -295,000 | -2,879 | 24,857,376 | ||||
| 2021-11-05 | 2021-11-03 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 9.2500 | -2,000,000 | -18,500 | 25,152,376 | ||||
| 2021-11-02 | 2021-10-29 | 4 | NODELMAN OLEG | NUVB | Stock Option (Right to Buy) | D | 9.17 | 45,229 | 45,229 | |||||
| 2021-11-02 | 2021-10-29 | 4 | BLICKENSTAFF KIM D | NUVB | Stock Option (Right to Buy) | D | 9.17 | 45,229 | 45,229 | |||||
| 2021-11-02 | 2021-10-29 | 4 | WELCH DANIEL G | NUVB | Stock Option (Right to Buy) | D | 9.17 | 45,229 | 45,229 | |||||
| 2021-11-02 | 2021-10-29 | 4 | FALBERG KATHRYN E | NUVB | Stock Option (Right to Buy) | D | 9.17 | 45,229 | 45,229 | |||||
| 2021-11-02 | 2021-10-29 | 4 | VERNON W ANTHONY | NUVB | Stock Option (Right to Buy) | D | 9.17 | 45,229 | 45,229 | |||||
| 2021-11-02 | 2021-10-29 | 4 | Bazemore Robert B | NUVB | Stock Option (Right to Buy) | D | 9.17 | 45,229 | 45,229 | |||||
| 2021-11-01 | 2021-10-29 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 9.2700 | -45,000 | -417 | 27,152,376 | ||||
| 2021-11-01 | 2021-10-28 | 4 | Omega Fund V, L.P. | NUVB | Common Stock | D | 9.6000 | -1,015,000 | -9,744 | 27,197,376 | ||||
| 2021-06-03 | 2021-06-01 | 4 | Hanley David C. | NUVB | Stock Option (Right to Buy) | D | 13.60 | 187,500 | 187,500 | |||||
| 2021-06-03 | 2021-06-01 | 4 | Hanley David C. | NUVB | Stock Option (Right to Buy) | D | 13.60 | 250,000 | 250,000 | |||||
| 2021-04-13 | 2021-04-13 | 4 | NODELMAN OLEG See Notes 1 and 3 | NUVB | Class A Common Stock | I | 10.2710 | 3,966 | 41 | 1,355,625 | ||||
| 2021-04-13 | 2021-04-13 | 4 | NODELMAN OLEG See Notes 1 and 2 | NUVB | Class A Common Stock | I | 10.2710 | 27,534 | 283 | 6,990,265 | ||||
| 2021-04-13 | 2021-04-12 | 4 | NODELMAN OLEG See Notes 1 and 3 | NUVB | Class A Common Stock | I | 9.4878 | 16,745 | 159 | 1,351,659 | ||||
| 2021-04-13 | 2021-04-12 | 4 | NODELMAN OLEG See Notes 1 and 2 | NUVB | Class A Common Stock | I | 9.4878 | 116,255 | 1,103 | 6,962,731 | ||||
| 2021-04-13 | 2021-04-09 | 4 | NODELMAN OLEG See Notes 1 and 3 | NUVB | Class A Common Stock | I | 10.0306 | 37,770 | 379 | 1,334,914 | ||||
| 2021-04-13 | 2021-04-09 | 4 | NODELMAN OLEG See Notes 1 and 2 | NUVB | Class A Common Stock | I | 10.0306 | 262,230 | 2,630 | 6,846,476 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Bazemore Robert B | NUVB | Class A Common Stock | D | 9.9799 | 5,000 | 50 | 5,000 | ||||
| 2021-03-11 | 2021-03-09 | 4 | Hung David | NUVB | Stock Option (Right to Buy) | D | 12.66 | 224,760 | 224,760 | |||||
| 2021-03-11 | 2021-03-09 | 4 | Hung David | NUVB | Stock Option (Right to Buy) | D | 12.66 | 165,465 | 165,465 | |||||
| 2021-02-26 | 2021-02-10 | 4 | Sharp Shalini | NUVB | Class B Common Stock | D | -25,000 | 0 | ||||||
| 2021-02-26 | 2021-02-10 | 4 | Sharp Shalini | NUVB | Class A Common Stock | D | 10.0000 | 10,000 | 100 | 35,000 | ||||
| 2021-02-26 | 2021-02-10 | 4 | Sharp Shalini | NUVB | Class A Common Stock | D | 25,000 | 25,000 | ||||||
| 2021-02-26 | 2021-02-10 | 4 | BRADBURY DANIEL | NUVB | Class B Common Stock | D | -25,000 | 0 | ||||||
| 2021-02-26 | 2021-02-10 | 4 | BRADBURY DANIEL | NUVB | Class A Common Stock | D | 25,000 | 25,000 | ||||||
| 2021-02-26 | 2021-02-10 | 4 | Hasnain Faheem | NUVB | Class B Common Stock | D | -25,000 | 0 | ||||||
| 2021-02-26 | 2021-02-10 | 4 | Hasnain Faheem | NUVB | Class A Common Stock | D | 10.0000 | 30,000 | 300 | 55,000 | ||||
| 2021-02-26 | 2021-02-10 | 4 | Hasnain Faheem | NUVB | Class A Common Stock | D | 25,000 | 25,000 | ||||||
| 2021-02-26 | 2021-02-10 | 4 | COOPER GRAHAM K | NUVB | Class B Common Stock | D | -25,000 | 0 | ||||||
| 2021-02-26 | 2021-02-10 | 4 | COOPER GRAHAM K | NUVB | Class A Common Stock | D | 25,000 | 25,000 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Warrant (Right to Buy) | I | 11.50 | 131,333 | 131,333 | |||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Warrant (Right to Buy) | I | 11.50 | 702,000 | 702,000 | |||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Liability Company | NUVB | Warrant (Right to Buy) | I | 11.50 | 130,000 | 130,000 | |||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Liability Company | NUVB | Class B Common Stock | I | -2,775,000 | 0 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Class A Common Stock | I | 2,200,627 | 2,200,627 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Class A Common Stock | I | 515,879 | 1,297,144 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Class A Common Stock | I | 2,365,511 | 6,584,246 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Class A Common Stock | I | 10.0000 | 387,265 | 3,873 | 781,265 | ||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Class A Common Stock | I | 10.0000 | 2,112,735 | 21,127 | 4,218,735 | ||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Class A Common Stock | I | 394,000 | 394,000 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Partnership | NUVB | Class A Common Stock | I | 2,106,000 | 2,106,000 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | NODELMAN OLEG By Limited Liability Company | NUVB | Class A Common Stock | I | 2,775,000 | 3,165,000 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | Omega Fund V, L.P. | NUVB | Series A Preferred Stock | D | -8,130,097 | 0 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | Omega Fund V, L.P. | NUVB | Class A Common Stock | D | 10.0000 | 500,000 | 5,000 | 28,212,373 | ||||
| 2021-02-12 | 2021-02-10 | 4 | Omega Fund V, L.P. | NUVB | Class A Common Stock | D | 8,130,097 | 27,712,373 | ||||||
| 2021-02-12 | 3 | DOIG MICHELLE | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 2021-02-10 | 4 | VERNON W ANTHONY | NUVB | Stock Option (Right to Buy) | D | 1.74 | 187,658 | 187,658 | |||||
| 2021-02-12 | 2021-02-10 | 4 | VERNON W ANTHONY | NUVB | Stock Option (Right to Buy) | D | 4.60 | 51,703 | 51,703 | |||||
| 2021-02-12 | 2020-02-10 | 4 | VERNON W ANTHONY | NUVB | Class A Common Stock | D | 10.0000 | 50,000 | 500 | 304,100 | ||||
| 2021-02-12 | 2020-02-10 | 4 | VERNON W ANTHONY | NUVB | Class A Common Stock | D | 254,100 | 254,100 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | FALBERG KATHRYN E | NUVB | Stock Option (Right to Buy) | D | 4.60 | 239,361 | 239,361 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Bazemore Robert B | NUVB | Stock Option (Right to Buy) | D | 1.74 | 187,658 | 187,658 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Bazemore Robert B | NUVB | Stock Option (Right to Buy) | D | 4.60 | 51,703 | 51,703 | |||||
| 2021-02-12 | 2021-02-10 | 4 | BLICKENSTAFF KIM D | NUVB | Stock Option (Right to Buy) | D | 1.74 | 187,658 | 187,658 | |||||
| 2021-02-12 | 2021-02-10 | 4 | BLICKENSTAFF KIM D | NUVB | Stock Option (Right to Buy) | D | 4.60 | 51,703 | 51,703 | |||||
| 2021-02-12 | 2021-02-10 | 4 | WELCH DANIEL G | NUVB | Stock Option (Right to Buy) | D | 1.74 | 312,750 | 312,750 | |||||
| 2021-02-12 | 2021-02-10 | 4 | WELCH DANIEL G | NUVB | Stock Option (Right to Buy) | D | 4.60 | 86,184 | 86,184 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Markel Stacy | NUVB | Stock Option (Right to Buy) | D | 1.74 | 254,810 | 254,810 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Markel Stacy | NUVB | Stock Option (Right to Buy) | D | 4.60 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Hattersley Gary | NUVB | Stock Option (Right to Buy) | D | 1.74 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Hattersley Gary | NUVB | Stock Option (Right to Buy) | D | 4.60 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Templeman Thomas | NUVB | Stock Option (Right to Buy) | D | 1.74 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Templeman Thomas | NUVB | Stock Option (Right to Buy) | D | 4.60 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Fox Jennifer A. | NUVB | Stock Option (Right to Buy) | D | 4.60 | 558,506 | 558,506 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Fox Jennifer A. | NUVB | Stock Option (Right to Buy) | D | 4.60 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Yurasov Sergey | NUVB | Stock Option (Right to Buy) | D | 4.60 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Yurasov Sergey | NUVB | Stock Option (Right to Buy) | D | 1.74 | 398,935 | 398,935 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Hung David | NUVB | Class B Common Stock | D | 1,000,000 | 1,000,000 | ||||||
| 2021-02-12 | 2021-02-10 | 4 | Hung David | NUVB | Class A Common Stock | D | 10.0000 | 2,000,000 | 20,000 | 58,645,012 | ||||
| 2021-02-12 | 2021-02-10 | 4 | Hung David | NUVB | Class A Common Stock | D | 56,645,012 | 56,645,012 | ||||||
| 2021-02-12 | 3 | FALBERG KATHRYN E | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | VERNON W ANTHONY | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | BLICKENSTAFF KIM D | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | Bazemore Robert B | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | WELCH DANIEL G | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | Markel Stacy | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | Hattersley Gary | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | Templeman Thomas | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | Yurasov Sergey | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | Fox Jennifer A. | NUVB | No securities owned. | D | 0 | ||||||||
| 2021-02-12 | 3 | Hung David | NUVB | No securities owned. | D | 0 | ||||||||
| 2020-07-06 | 2020-07-06 | 4 | EcoR1 Panacea Holdings, LLC | PANA | Class A common stock | D | 10.0000 | 390,000 | 3,900 | 390,000 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
